Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert B Innis

Showing results (121-130 of 256) with videos related to

Pageof 26
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 geneChristopher H van Dyck, Robert T Malison, Leslie K Jacobsen, et al.
ACS Pharmacology & Translational Science|April 21, 2023
Discovery of a High-Affinity Fluoromethyl Analog of [<sup>11</sup>C]5-Cyano-<i>N</i>-(4-(4-methylpiperazin-1-yl)-2-(piperidin-1-yl)phenyl)furan-2-carboxamide ([<sup>11</sup>C]CPPC) and Their Comparison in Mouse and Monkey as Colony-Stimulating Factor 1 Receptor Positron Emission Tomography RadioligandsStefano Altomonte, Xuefeng Yan, Cheryl L Morse, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
PET imaging of the dopamine transporter with 18F-FECNT: a polar radiometabolite confounds brain radioligand measurementsSami S Zoghbi, H Umesha Shetty, Masanori Ichise, et al.
Journal of Medicinal Chemistry|January 6, 2009
Single-step high-yield radiosynthesis and evaluation of a sensitive 18F-labeled ligand for imaging brain peripheral benzodiazepine receptors with PETEmmanuelle Briard, Sami S Zoghbi, Fabrice G Siméon, et al.
Synapse (New York, N.Y.)|January 19, 2007
PET imaging of neurokinin-1 receptors with [(18)F]SPA-RQ in human subjects: assessment of reference tissue models and their test-retest reproducibilityFumihiko Yasuno, Sandra M Sanabria, Donald Burns, et al.
The American Journal of Psychiatry|March 3, 2004
Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotypeChristopher H van Dyck, Robert T Malison, Julie K Staley, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 11, 2006
Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2IH Umesha Shetty, Sami S Zoghbi, Jeih-San Liow, et al.
Psychopharmacology|June 1, 2011
Occupancy of dopamine D₂ and D₃ and serotonin 5-HT₁A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomographyNicholas Seneca, Sjoerd J Finnema, István Laszlovszky, et al.
Neuroimage|January 26, 2010
D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse modelMette Skinbjerg, Jeih-San Liow, Nicholas Seneca, et al.
Schizophrenia Research|August 23, 2012
Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophreniaKimberly J Jenko, Jussi Hirvonen, Ioline D Henter, et al.
Pageof 26

Showing results (121-130 of 256) with videos related to

Sort By:
Pageof 26
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 geneChristopher H van Dyck, Robert T Malison, Leslie K Jacobsen, et al.
ACS Pharmacology & Translational Science|April 21, 2023
Discovery of a High-Affinity Fluoromethyl Analog of [<sup>11</sup>C]5-Cyano-<i>N</i>-(4-(4-methylpiperazin-1-yl)-2-(piperidin-1-yl)phenyl)furan-2-carboxamide ([<sup>11</sup>C]CPPC) and Their Comparison in Mouse and Monkey as Colony-Stimulating Factor 1 Receptor Positron Emission Tomography RadioligandsStefano Altomonte, Xuefeng Yan, Cheryl L Morse, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
PET imaging of the dopamine transporter with 18F-FECNT: a polar radiometabolite confounds brain radioligand measurementsSami S Zoghbi, H Umesha Shetty, Masanori Ichise, et al.
Journal of Medicinal Chemistry|January 6, 2009
Single-step high-yield radiosynthesis and evaluation of a sensitive 18F-labeled ligand for imaging brain peripheral benzodiazepine receptors with PETEmmanuelle Briard, Sami S Zoghbi, Fabrice G Siméon, et al.
Synapse (New York, N.Y.)|January 19, 2007
PET imaging of neurokinin-1 receptors with [(18)F]SPA-RQ in human subjects: assessment of reference tissue models and their test-retest reproducibilityFumihiko Yasuno, Sandra M Sanabria, Donald Burns, et al.
The American Journal of Psychiatry|March 3, 2004
Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotypeChristopher H van Dyck, Robert T Malison, Julie K Staley, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 11, 2006
Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2IH Umesha Shetty, Sami S Zoghbi, Jeih-San Liow, et al.
Psychopharmacology|June 1, 2011
Occupancy of dopamine D₂ and D₃ and serotonin 5-HT₁A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomographyNicholas Seneca, Sjoerd J Finnema, István Laszlovszky, et al.
Neuroimage|January 26, 2010
D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse modelMette Skinbjerg, Jeih-San Liow, Nicholas Seneca, et al.
Schizophrenia Research|August 23, 2012
Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophreniaKimberly J Jenko, Jussi Hirvonen, Ioline D Henter, et al.
Pageof 26